However, I will be evaluating certain companies in the Pharmaceutical industry:
Courtesy of Wiki:
The following is a list of the twelve largest pharmaceutical companies ranked by revenue as of July 2009[update] in the Fortune Global 500.[1]
Rank[1]  | Company | Country | Total Revenues (USD millions) | Net income/ (loss) (USD millions) | Employees |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | United States | 63,747.0[2] | 12,949.0 | 118,700 |
| 2 | Pfizer | United States | 48,296.0[3] | 8,104.0 | 81,800 |
| 3 | GlaxoSmithKline | United Kingdom | 44,654.0[4] | 8,438.6 | 99,003 |
| 4 | Roche | Switzerland | 44,267.5[5] | 8,288.1 | 80,080 |
| 5 | Sanofi-Aventis | France | 42,179.0[6] | 5,636.7 | 98,213 |
| 6 | Novartis | Switzerland | 41,459.0[7] | 8,195.0 | 96,717 |
| 7 | AstraZeneca | United Kingdom | 31,601.0[8] | 6,101.0 | 65,000 |
| 8 | Abbott Laboratories | United States | 29,527.6[9] | 4,880.7 | 68,838 |
| 9 | Merck | United States | 23,850.3[10] | 7,808.4 | 55,200 |
| 10 | Wyeth | United States | 22,833.9[11] | 4,417.8 | 47,426 |
| 11 | Bristol-Myers Squibb | United States | 21,366.0[12] | 5,247.0 | 35,000 |
| 12 | Eli Lilly | United States | 20,378.0[13] | (2,071.9) | 40,500 |
Why Pharmy and not other industries?
Well, my intention is not craved in stoned but thinking out loud on a lazy Saturday afternoon, I intend to do much fundamental and technical research and analysis on this industry and of course ask myself the million dollar question, "How much?" before plonking down any cent.
My base is still Forex and I do have the capacity at this point of time for investing in some long term stocks not because we are in a bull cycle but because I am in the process of being a defensive to enterprising investor.
